Spots Global Cancer Trial Database for stage iv lung cancer

Every month we try and update this database with for stage iv lung cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer	NCT04614103	Metastatic Non ...	LN-145 LN-145	18 Years - 70 Years	Iovance Biotherapeutics, Inc.
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer	NCT05361174	Unresectable Me... Metastatic Mela... Stage III Non-s... Stage IV Non-sm...	IOV-4001	18 Years -	Iovance Biotherapeutics, Inc.
A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources	NCT06383988	Stage II Lung C... Stage III Lung ... Stage IV Lung C...	Support for Car... Support for Car... Internet-Based ... Patient Navigat...	18 Years -	Wake Forest University Health Sciences
An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer	NCT06427369	Extensive-stage... Limited-stage S... Lung Non-Small ... Stage IIIA Lung... Stage IV Lung C...	Radioconjugate Positron Emissi... Computed Tomogr... FDG-Positron Em... Biospecimen Col...	18 Years -	Roswell Park Cancer Institute
A Computer-Based Intervention for Distance Caregivers of Parents With Advanced Cancer	NCT02128373	Stage IV Lung C... Malignant Brain...	Usual care computer-assist... Distress Thermo... Profile of Mood... Quality of Life... Tension-Anxiety...	18 Years -	Case Comprehensive Cancer Center
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy	NCT00858364	Non-Small Cell ... Anemia Cancer Lung Cancer	Darbepoetin alf... Placebo	18 Years -	Amgen
Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)	NCT01029925	Metastatic Brea... Lung Cancer	Dichloroacetate...	18 Years -	Jonsson Comprehensive Cancer Center
Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients	NCT03222258	Stage IV Breast... Stage IV Pancre... Stage IV Colon ... Stage IV Gastri... Stage IV Lung C... Stage IV Liver ... Malignant Hemat... Biliary Cancer ... Pediatric Leuke... Pediatric Lymph... Pediatric Brain... Pediatric Solid...	Early palliativ... Routine hospice...	-	Seoul National University Hospital
CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy	NCT02693080	Malignant Lung ... Metastatic Mali... Non-Small Cell ... Stage IV Lung C...	CAPP-Seq Isovue-200 Computed Tomogr...	18 Years -	Stanford University
Lung Cancer Informational Study (LCIS)	NCT00579215	Cancer Enhanced Care Decision-Making Advance Lung Ca... Stage III Lung ... Stage IV Lung C...	Enhance Care Usual Care	-	Memorial Sloan Kettering Cancer Center
Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer	NCT01829113	Non Squamous No...	OGX-427 Placebo	18 Years -	SCRI Development Innovations, LLC
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites	NCT04267575	Recurrent Malig... Stage IV Breast... Stage IV Prosta... Stage IV Pancre... Stage IV Non-sm... Stage IV Ovaria... Stage IV Fallop... Stage IV Colon ... Stage IV Colore... Stage IV Liver ... Stage IV Renal ... Stage IV Rectal... Stage IV Lung C... Stage IV Small ... Stage IV Gastri... Stage IV Bladde...	Canady Helios C...	18 Years -	Jerome Canady Research Institute for Advanced Biological & Technological Sciences
Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer	NCT02087241	Previously Untr...	AZD1775 AZD1775 Matchin... pemetrexed carboplatin	18 Years -	AstraZeneca
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies	NCT03329950	Melanoma Non-small Cell ... Breast Cancer Gastric Cancer Renal Cell Carc... Ovarian Cancer Cholangiocarcin... Bladder Urothel... Pancreatic Aden... Colorectal Canc... Esophageal Canc... Hepatic Cancer Head and Neck C... Primary Periton... Fallopian Tube ... Other Solid Tum... Diffuse Large B... Mantle Cell Lym... Indolent B-cell... Non-Hodgkin Lym... Follicular Lymp... Lymphoplasmacyt... Waldenstrom's D... Marginal Zone L... Mucosa Associat... Small Lymphocyt...	CDX-1140 CDX-301 pembrolizumab Chemotherapy	18 Years -	Celldex Therapeutics
Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR	NCT01556191	Stage IV Lung C...	Gefitinib Fulvestrant Erlotinib	18 Years -	Intergroupe Francophone de Cancerologie Thoracique
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites	NCT04267575	Recurrent Malig... Stage IV Breast... Stage IV Prosta... Stage IV Pancre... Stage IV Non-sm... Stage IV Ovaria... Stage IV Fallop... Stage IV Colon ... Stage IV Colore... Stage IV Liver ... Stage IV Renal ... Stage IV Rectal... Stage IV Lung C... Stage IV Small ... Stage IV Gastri... Stage IV Bladde...	Canady Helios C...	18 Years -	Jerome Canady Research Institute for Advanced Biological & Technological Sciences
Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer	NCT04005144	ALK Gene Rearra... Lung Non-Small ... Progressive Dis... ROS1 Gene Rearr... Stage IIIB Lung... Stage IIIC Lung... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ...	Binimetinib Brigatinib	18 Years -	University of California, San Francisco
Truthful Information on Chemotherapy and Its Impact on Chemotherapy at the End of Life	NCT02606149	Stage IV Lung C...	Truthful inform... Standard of inf...	18 Years -	Assistance Publique - Hôpitaux de Paris
Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer	NCT04005144	ALK Gene Rearra... Lung Non-Small ... Progressive Dis... ROS1 Gene Rearr... Stage IIIB Lung... Stage IIIC Lung... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ...	Binimetinib Brigatinib	18 Years -	University of California, San Francisco
Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)	NCT01029925	Metastatic Brea... Lung Cancer	Dichloroacetate...	18 Years -	Jonsson Comprehensive Cancer Center
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies	NCT03329950	Melanoma Non-small Cell ... Breast Cancer Gastric Cancer Renal Cell Carc... Ovarian Cancer Cholangiocarcin... Bladder Urothel... Pancreatic Aden... Colorectal Canc... Esophageal Canc... Hepatic Cancer Head and Neck C... Primary Periton... Fallopian Tube ... Other Solid Tum... Diffuse Large B... Mantle Cell Lym... Indolent B-cell... Non-Hodgkin Lym... Follicular Lymp... Lymphoplasmacyt... Waldenstrom's D... Marginal Zone L... Mucosa Associat... Small Lymphocyt...	CDX-1140 CDX-301 pembrolizumab Chemotherapy	18 Years -	Celldex Therapeutics
Truthful Information on Chemotherapy and Its Impact on Chemotherapy at the End of Life	NCT02606149	Stage IV Lung C...	Truthful inform... Standard of inf...	18 Years -	Assistance Publique - Hôpitaux de Paris
CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy	NCT02693080	Malignant Lung ... Metastatic Mali... Non-Small Cell ... Stage IV Lung C...	CAPP-Seq Isovue-200 Computed Tomogr...	18 Years -	Stanford University
Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation	NCT06110572	Extensive Stage... Stage IV Lung C...	Carboplatin Atezolizumab Etoposide Total Body Irra... Hypofractionate... Magnetic Resona...	18 Years -	Vanderbilt-Ingram Cancer Center
Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer	NCT02087241	Previously Untr...	AZD1775 AZD1775 Matchin... pemetrexed carboplatin	18 Years -	AstraZeneca
Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients	NCT03222258	Stage IV Breast... Stage IV Pancre... Stage IV Colon ... Stage IV Gastri... Stage IV Lung C... Stage IV Liver ... Malignant Hemat... Biliary Cancer ... Pediatric Leuke... Pediatric Lymph... Pediatric Brain... Pediatric Solid...	Early palliativ... Routine hospice...	-	Seoul National University Hospital
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners	NCT03112668	Malignant Femal... Malignant Hepat... Partner Stage III Breas... Stage III Cervi... Stage III Color... Stage III Lung ... Stage III Prost... Stage III Skin ... Stage III Uteri... Stage IIIA Brea... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Lung... Stage IIIA Skin... Stage IIIA Uter... Stage IIIB Brea... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Lung... Stage IIIB Skin... Stage IIIB Uter... Stage IIIC Brea... Stage IIIC Colo... Stage IIIC Skin... Stage IIIC Uter... Stage IV Breast... Stage IV Cervic... Stage IV Colore... Stage IV Lung C... Stage IV Prosta... Stage IV Skin M... Stage IV Uterin... Stage IVA Cervi... Stage IVA Color... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Color... Stage IVB Uteri...	Cognitive Behav... Quality-of-Life... Questionnaire A... Survey Administ...	18 Years -	Rutgers, The State University of New Jersey
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs	NCT04985357	Stage III Breas... Stage IV Breast... Stage III Lung ... Stage IV Lung C... AML Multiple Myelom... Carcinoma Carcinoma, Panc... Carcinoma of Lu... Carcinoma, Non-... Carcinoma Breas... Carcinoma Prost... Carcinoma, Hepa... Carcinoma, Rena... Carcinoma, Neur... Carcinoma, Smal... Carcinoma, Ovar... Carcinoma Bladd... Carcinoma of Es... Carcinoma Cervi... Carcinoma, Thym... Carcinoma, Duct... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of Un... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Malignant Pleur... Malignant Ascit... Mesothelioma Cholangiocarcin...		18 Years -	Travera Inc
Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR	NCT01556191	Stage IV Lung C...	Gefitinib Fulvestrant Erlotinib	18 Years -	Intergroupe Francophone de Cancerologie Thoracique
Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skipping Mutation	NCT05435846	Metastatic Lung... Stage IV Lung C...	Capmatinib Trametinib	18 Years -	University of California, San Francisco
Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)	NCT02638090	Lung Cancer Non-small Cell ...	Vorinostat Pembrolizumab	18 Years -	H. Lee Moffitt Cancer Center and Research Institute
Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer	NCT01829113	Non Squamous No...	OGX-427 Placebo	18 Years -	SCRI Development Innovations, LLC
Ask Questions (ASQ):Implementation of a Communication Intervention	NCT05025748	Stage II Breast... Stage III Breas... Stage IV Breast... Stage II Colore... Stage III Color... Stage IV Colore... Stage II Lung C... Stage III Lung ... Stage IV Lung C... Stage II Prosta... Stage III Prost... Stage IV Prosta... Stage II Ovaria... Stage III Ovari... Stage IV Ovaria... Stage II Cervic... Stage III Cervi... Stage II Bladde... Stage III Bladd... Stage IV Bladde... Stage II Kidney... Stage III Kidne... Stage IV Kidney...	Behavioral Inte...	18 Years -	Barbara Ann Karmanos Cancer Institute
Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer	NCT03867175	Metastatic Lung... Stage IV Lung C...	Stereotactic Bo... Pembrolizumab	18 Years -	Wake Forest University Health Sciences
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy	NCT00858364	Non-Small Cell ... Anemia Cancer Lung Cancer	Darbepoetin alf... Placebo	18 Years -	Amgen
Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer	NCT02318771	Head and Neck S... Metastatic Rena... Recurrent Head ... Recurrent Lung ... Recurrent Renal... Recurrent Skin ... Stage III Renal... Stage IV Lung C... Stage IV Skin M...	Radiation Thera... MK-3475	18 Years -	Thomas Jefferson University
Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer	NCT00003492	Stage IV Lung C...	Antineoplaston ...	18 Years - 99 Years	Burzynski Research Institute

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: